Skip to main navigation
Main navigation
Patients
For Patients
About HCM
About DCM
Clinical Trials
Access Policy
Science
Our Scientific Approach
Publications & Presentations
Programs
Our Pipeline
Mavacamten
MYK-224
LUS-1
MYK-491
ACT-1
Researchers
For Researchers
Grants & Funding
Investors
Press Releases
Events & Presentations
FAQ
Careers
Become a Myokardian
Current Opportunities
About
About Myokardia
Our Leadership
Our History
Life at MyoKardia
Contact Us
Menu
Investors & Media
Menu
Press Releases
Events & Presentations
Analyst Coverage
Investor FAQ
Online Investor Kit
Investor Relations Contact
Michelle Corral
MyoKardia, Inc.
650-351-4690
ir@myokardia.com
SHAREHOLDER TOOLS
PRINT PAGE
E-MAIL ALERTS
SHARE
IR CONTACT
RSS FEEDS
Facebook
Google
LinkedIn
Twitter
Main navigation
Patients
For Patients
About HCM
About DCM
Clinical Trials
Access Policy
Science
Our Scientific Approach
Publications & Presentations
Programs
Our Pipeline
Mavacamten
MYK-224
LUS-1
MYK-491
ACT-1
Researchers
For Researchers
Grants & Funding
Investors
Press Releases
Events & Presentations
FAQ
Careers
Become a Myokardian
Current Opportunities
About
About Myokardia
Our Leadership
Our History
Life at MyoKardia
Contact Us